Brave New World (no pun!) [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2013-01-22 00:06 (4534 d 16:13 ago) – Posting: # 9895
Views: 5,427

Sequential Designs and Interim Analyses
in Bioequivalence: FDA’s
Experience


Barbara M. Davit, Ph.D., J.D.
Director, Division of Bioequivalence II
Office of Generic Drugs, CDER, FDA

Mini-Symposium on Adaptive Study Designs and Assessment
Approaches for Bioequivalence
AAPS Annual Meeting
Chicago, IL
October 13-18, 2012


[image]

[image]



P.S.: No slide about Method B. :-D

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
56 visitors (0 registered, 56 guests [including 11 identified bots]).
Forum time: 17:19 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5